Svetlana Pasteuning-Vuhman, MSc.
Svetlana Pasteuning-Vuhman was a Ph.D. student in the DMD Genetic Therapy Group since February 2013. She was studying the role of TGF-β/myostatin signaling and its contributes to DMD pathology. She was also budy with the development of a method to selectively inhibit the function of type I TGF-β receptors based on antisense oligonucleotide-mediated exon skipping as a potential therapy for DMD.
Click here to see the publication list of Svetlana Pasteuning-Vuhman